Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Oncology Research and Treatment|October 5, 2018
Cell-Free DNA and Neuromediators in Detecting Aggressive Variant Prostate CancerJost von Hardenberg, Thomas S Worst, Niklas Westhoff, et al.The Prostate|July 13, 2007
The combination of antagonists of LHRH with antagonists of GHRH improves inhibition of androgen sensitive MDA-PCa-2b and LuCaP-35 prostate cancersAnton Stangelberger, Andrew V Schally, Marta Zarandi, et al.The Prostate|August 30, 2008
Dose-dependent growth inhibition in vivo of PC-3 prostate cancer with a reduction in tumoral growth factors after therapy with GHRH antagonist MZ-J-7-138Elmar Heinrich, Andrew V Schally, Stefan Buchholz, et al.Virchows Archiv : an International Journal of Pathology|February 13, 2008
Molecular genetic findings in two cases of sarcomatoid carcinoma of the ureter: evidence for evolution from a common pluripotent progenitor cell?Hans-Ullrich Völker, Andreas Zettl, Georg Schön, et al.Proceedings of the National Academy of Sciences of the United States of America|September 20, 2006
Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxelFlorian Hohla, Andrew V Schally, Karoly Szepeshazi, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|May 21, 2022
Acidification of 24-hour urine in urolithiasis risk testing: An obsolete relic?Janne Cadamuro, Cosima Decho, Glynis Frans, et al.European Urology|November 3, 2012
Cabazitaxel plus prednisone for metastatic castration-resistant prostate cancer progressing after docetaxel: results from the German compassionate-use programmeAxel Heidenreich, Hans-Jörg Scholz, Sebastian Rogenhofer, et al.Clinical Genitourinary Cancer|January 24, 2024
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter StudyMona Kafka, Giulia Giannini, Nastasiia Artamonova, et al.Pageof 3